Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure

Journal of Hepatology

Volumn 29, Issue 1, 1998, Pages 53-59

  Bernal, William ^a   Donaldson, Peter ^a   Underhill, James ^a   Wendon, Julia ^a   Williams, Roger ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Acetaminophen; Acute liver failure; HLA; Paracetamol; Tumor necrosis factor

Indexed keywords

PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; HEPATIC ENCEPHALOPATHY; HLA TYPING; HUMAN; LIVER FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032125487     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80178-5     Document Type: Article

References (32)

1. Makin A, Wendon J, Williams R. A 7 year experience of severe acetominophen-induced hepatotoxicity (1987-1993). Gastroenterology. 109:1995;1907-1916.
2. Laskin D, Gardner C, Price V, Jollow D. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetominophen. Hepatology. 21:1995;1045-1050.
3. Goldin R, Ratnayaka I, Breach C, Brown I, Wickramasinghe S. Role of macrophages in acetaminophen (paracetomol) induced hepatotoxicity. J Pathol. 179:1995;432-435.
4. Blazka M, Wilmer J, Holladay S, Wilson R, Luster M. Role of proinflammatory cytokines in acetominophen hepatotoxicity. Toxico Appl Pharmacol. 133:1995;43-52.
5. Rolando N, Ellis A, Groote DD, Wendon J, Williams R. Correlation of serial cytokine levels with progression to coma (grade IV) in patients with acute liver failure. [abstract] Hepatology. 22:1995;366.
6. Moldawer L. Biology of proinflammatory cytokines and their antagonist. Crit Care Med. 22:1994;S3-S7.
7. Endres S, Cannon J, Ghorbari R, Dempsey R, Sissun S, Lannemann G, et al. In vitro production of IL-1, alpha, IL-1 beta, TNF, and IL-2 in healthy subjects; distrubution, effect of cycloxygenase inhibition and evidence of independent gene regulation. Eur J Immunol. 19:1989;2327-2333.
8. Dannis V, Millington M, Hyland V, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist gene polymorphism. Clin Exp Immunol. 99:1995;303-310.
9. Wilson A, Giovine FD, Duff G. Genetics of TNFa in autoimmune, infectious and neoplastic diseases. J Inflamm. 45:1995;1-12.
10. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaee H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatability alleles with the secretion of TNF alpha and TNF beta by human mononuclear cells: a possible link to insulin dependant diabetes mellitus. Eur J Immunol. 23:1993;224-231.
11. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 24:1996;381-384.
12. Cox A, Gonzalez A, Wilson A, Wilson R, Ward J, Arlet C, et al. Comparative analysis of the genetic associations of HLA-DR3 and tumor necrosis factor alpha with human IDDM. Diabetologia. 37:1994;500-503.
13. Wendon J, Williams R. Acute liver failure. Williams R, Portmann B, Tan K. The Practice of Liver Transplantation. 1995;93-103 Churchill Livingstone, Edinburgh.
14. O'Grady J, Alexander G, Haylar K, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 97:1989;439-445.
15. Knauss W, Wagner D, Draper E, Zimmerman J, Bergner M, Bastas P, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults. Chest. 100:1991;1619-1636.
16. Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transportation for acute liver failure. Hepatology. 21:1995;1018-1024.
17. *103 allele confers protection from chronic HCV infection in Northern European caucasoids. Hepatology. 24:1996;1342-1345.
18. Mcguire W, Hill V, Allsopp C, Greenwood B, Kwjatkowski D. Variation of TNF-alpha promotor region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
19. Hayes M, Timmins A, Yau E, Palazzo M, Watson D, Hinds C. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med. 25:1997;926-936.
20. Bihari D, Gimson A, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis. 6:1986;119-128.
21. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infections in acute liver failure. Semin Liver Dis. 16:1996;389-402.
22. Mata MD, Meager A, Rolando N, Daniels HM, Nouri-Aka KT, Goka AKJ, et al. Tumour necrosis factor production in fulminant hepatic failure; relation to aetiology and superimposed microbial infection. Clin Exp Immunol. 82:1990;479-484.
23. Bettinotti M, Hartung K, Deicher H, Messer G, Kelly E, Weiss E, et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosis: TNF-MHC haplotypes. Immunogenetics. 37:1993;449-454.
24. Rolando N, Harvey F, Brahm J, Philpot-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure; an analysis of fifty patients. Hepatology. 11:1990;50-53.
25. Rolando N, Wade J, Stangou A, Gimson A, Wenden J, Philpot-Howard J, et al. Prospective study comparing prophylactic parenteral antimicrobials, with or without enteral decontamination in patients with acute liver failure. Liver Transplant Surg. 2:1996;8-13.
26. Munoz S, Moritz M, Bell R, Northrup B, Martin P, Radomski J. Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation. Transplantation. 55:1993;1071-1074.
27. Dejana E, Corada M, Lampugnani M. Endothelial cell-to-cell junctions. FASEB J. 9:1995;910-917.
28. Sharief M, Ciardi M, Thompson E. Blood-brain barrier damage in patients with bacterial meningitis; association with tumor necrosis factor-α but not interleukin-1β J Infect Dis. 166:1992;350-358.
29. Vries HD, Blom-Roosemalen M, Oosten MV, Boer AD, Berkel TU, Breimer D, et al. The influence of cytokines on the blood-brain barrier in vitro. J Neuroimmunol. 64:1996;37-43.
30. Rockett K, Awburn M, Aggarwall B. In vivo induction of nitrate/nitrite by TNF, LT and IL-1; roles in malaria. Infect Immunol. 60:1992;3725-3730.
31. Estrada C, Gomez C, Martin C. Effects of TNF-alpha on the production of vasoactive substances by cerebral endothelial and smooth muscle cells. J Cereb Blood Flow Metab. 15:1995;920-928.
32. Clark I, Rockett K, Cowden W. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet. 340:1992;894-895.